Telerehabilitation for Hip and Knee Osteoarthritis

NCT ID: NCT06901661

Last Updated: 2025-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-30

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Digital health utilization in the form of telerehabilitation is a popular technology that is very little researched for musculoskeletal disorders particularly hip and knee osteoarthritis (OA). The progression of OA will lead to total hip or knee replacement surgery. As a consequence, the advancing aging population leads to an increased burden on the healthcare system due to rising osteoarthritis. That's why, we will conduct a randomized controlled trial to explore the effectiveness of telerehabilitation in hip and knee osteoarthritis. This study will recruit OA patients into control and experimental groups. The control group will receive a patient education while the experimental group will undergo remote exercise sessions. Both groups will receive one supervised session a week for 5 weeks. The pre- and post-outcome measures will be recorded for functional status of hip and knee, muscle strength, and range of motions of the lower extremity. This innovative study will evaluate the effectiveness of a telemedicine intervention applied to a clinical population in Taiwan. The use of telerehabilitation interventions aims to reduce treatment and transportation costs, as well as save time for patients with OA. This digital health approach also helps to alleviate the workload of physiotherapists and rehabilitation doctors in clinics. The findings from this study could broaden the scope for using remote digital technology to assist clinical patients in diverse settings, especially those with limited or no hospital access.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose: To conduct a randomized controlled trial to explore the efficacy of telerehabilitation intervention for 5 weeks in a clinical population with hip and knee osteoarthritis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Knee Osteoarthritis, Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telerehabilitation

Receive a remote exercise program for 40 minutes once a week for 5 weeks

Group Type EXPERIMENTAL

Telerehabilitation

Intervention Type BEHAVIORAL

Exercise program include Warm-up, Targeted muscle Strengthening, Joint mobilization, and Proprioception

Standard care

Receive a patient education session once a week for 5 weeks

Group Type PLACEBO_COMPARATOR

Standard care

Intervention Type BEHAVIORAL

Education session on their pain, disability, and functional activities

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telerehabilitation

Exercise program include Warm-up, Targeted muscle Strengthening, Joint mobilization, and Proprioception

Intervention Type BEHAVIORAL

Standard care

Education session on their pain, disability, and functional activities

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. diagnosed with hip or knee osteoarthritis within last one year
2. having sub-acute or chronic symptoms of pain and functional disability
3. living in an area served by high-speed Internet services (at least 512 kb/s in upload)
4. living within an hour driving distance from the treating hospital
5. physically fit to provide a written consent to participate in this study

Exclusion Criteria

1. taking sedatives, autoimmune, or other medication that can interfere with their exercise program
2. any health issues that could affect the tests or the rehabilitation program, including surgery over the recent six months
3. having diagnosed with cognitive disorders
4. having recent surgery or major postoperative complications
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University Shuang Ho Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hung-Chou Chen, Dr.

Role: PRINCIPAL_INVESTIGATOR

Taipei Medical University Shuang Ho Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare

New Taipei City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Muhammad Adeel, Dr.

Role: CONTACT

+886-2-86741111 ext. 67123

Hung-Chou Chen, Dr.

Role: CONTACT

+886-2-22490088

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hung-Chou Chen, Dr.

Role: primary

+886-2-22490088 ext. 1603

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TMU-IJRB-N202412017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.